Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Epirubicin hydrochloride |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Idarubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Doxorubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
anthracyclin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
1 |
Product containing epirubicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitoxantrone (substance) |
Is a |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Valrubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Aclarubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Product containing mitoxantrone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml koncentrat til infusionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml koncentrat til infusionsvæske, hætteglas a 12,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml koncentrat til infusionsvæske, hætteglas a 15 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml infusionsvæske, opløsning, hætteglas a 22,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml infusionsvæske, opløsning, hætteglas a 45 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
mitoxantron 2 mg/ml koncentrat til infusionsvæske, hætteglas a 15 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Mitoxantrone hydrochloride 2mg/mL infusion concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
mitoxantronhydrochlorid 1 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 50 mg/25 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 10 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 20 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Product containing precisely epirubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 100 mg/50 ml blæreinstillationsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 80 mg/50 ml blæreinstillationsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 2 mg/ml infusionsvæske, opløsning, hætteglas a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicinhydrochlorid 50 mg/50 ml blæreinstillationsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicinhydrochloridprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin hydrochloride 2mg/mL injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
epirubicin 2 mg/ml, opløsning til injektion, hætteglas a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Epirubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Pirarubicin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin hydrochloride |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Doxorubicin hydrochloride |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin citrate liposome (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin liposome (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin hydrochloride liposome (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Doxorubicin liposome (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Idarubicin hydrochloride |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Daunorubicin citrate |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Doxorubicin hydrochloride pegylated liposome |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Aclarubicin hydrochloride (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Plicamycin (substance) |
Is a |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
|
Dilated cardiomyopathy caused by anthracycline |
Causative agent |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
1 |
Anthracycline therapy |
Direct substance |
True |
Anthracycline (substance) |
Inferred relationship |
Some |
1 |